These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12824787)

  • 1. Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa.
    Leroy V; Karon JM; Alioum A; Ekpini ER; van de Perre P; Greenberg AE; Msellati P; Hudgens M; Dabis F; Wiktor SZ;
    AIDS; 2003 Jul; 17(10):1493-501. PubMed ID: 12824787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant.
    Dabis F; Msellati P; Meda N; Welffens-Ekra C; You B; Manigart O; Leroy V; Simonon A; Cartoux M; Combe P; Ouangré A; Ramon R; Ky-Zerbo O; Montcho C; Salamon R; Rouzioux C; Van de Perre P; Mandelbrot L
    Lancet; 1999 Mar; 353(9155):786-92. PubMed ID: 10459959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa.
    Leroy V; Karon JM; Alioum A; Ekpini ER; Meda N; Greenberg AE; Msellati P; Hudgens M; Dabis F; Wiktor SZ;
    AIDS; 2002 Mar; 16(4):631-41. PubMed ID: 11873008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial.
    Wiktor SZ; Ekpini E; Karon JM; Nkengasong J; Maurice C; Severin ST; Roels TH; Kouassi MK; Lackritz EM; Coulibaly IM; Greenberg AE
    Lancet; 1999 Mar; 353(9155):781-5. PubMed ID: 10459958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children. DITRAME ANRS 049 Study Group.
    Lancet; 1999 Dec; 354(9195):2050-1. PubMed ID: 10636375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Field acceptability and effectiveness of the routine utilization of zidovudine to reduce mother-to-child transmission of HIV-1 in West Africa.
    Meda N; Leroy V; Viho I; Msellati P; Yaro S; Mandelbrot L; Montcho C; Manigart O; Dabis F;
    AIDS; 2002 Nov; 16(17):2323-8. PubMed ID: 12441805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in Cote d'Ivoire.
    Jamieson DJ; Sibailly TS; Sadek R; Roels TH; Ekpini ER; Boni-Ouattara E; Karon JM; Nkengasong J; Greenberg AE; Wiktor SZ
    J Acquir Immune Defic Syndr; 2003 Dec; 34(4):430-6. PubMed ID: 14615662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F; Bequet L; Ekouevi DK; Viho I; Rouet F; Horo A; Sakarovitch C; Becquet R; Fassinou P; Dequae-Merchadou L; Welffens-Ekra C; Rouzioux C; Leroy V;
    AIDS; 2005 Feb; 19(3):309-18. PubMed ID: 15718842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18-Month mortality and perinatal exposure to zidovudine in West Africa.
    Dabis F; Elenga N; Meda N; Leroy V; Viho I; Manigart O; Dequae-Merchadou L; Msellati P; Sombie I;
    AIDS; 2001 Apr; 15(6):771-9. PubMed ID: 11371692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine.
    Ekpini RA; Nkengasong JN; Sibailly T; Maurice C; Adjé C; Monga BB; Roels TH; Greenberg AE; Wiktor SZ
    AIDS; 2002 Mar; 16(4):625-30. PubMed ID: 11873007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission.
    Leroy V; Ekouevi DK; Becquet R; Viho I; Dequae-Merchadou L; Tonwe-Gold B; Rouet F; Sakarovitch C; Horo A; Timité-Konan M; Rouzioux C; Dabis F;
    PLoS One; 2008 Feb; 3(2):e1645. PubMed ID: 18286200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial.
    Leroy V; Montcho C; Manigart O; Van de Perre P; Dabis F; Msellati P; Meda N; You B; Simonon A; Rouzioux C;
    AIDS; 2001 Mar; 15(4):517-22. PubMed ID: 11242149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Shaffer N; Chuachoowong R; Mock PA; Bhadrakom C; Siriwasin W; Young NL; Chotpitayasunondh T; Chearskul S; Roongpisuthipong A; Chinayon P; Karon J; Mastro TD; Simonds RJ
    Lancet; 1999 Mar; 353(9155):773-80. PubMed ID: 10459957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
    JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial.
    Petra Study Team
    Lancet; 2002 Apr; 359(9313):1178-86. PubMed ID: 11955535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.